Pediatric heparin-induced thrombocytopenia: Prevalence, thrombotic risk, and application of the 4Ts scoring system

Journal of Pediatrics

Volumn 166, Issue 1, 2015, Pages 144-150.e1

  Obeng, Esther A ^a,b   Harney, Kathy M ^a   Moniz, Thomas ^a   Arnold, Alana ^a   Neufeld, Ellis J ^a,b   Trenor, Cameron C ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ELISA; Enzyme linked immunosorbent assay; HEP; Heparin induced thrombocytopenia; HIT; Hit expert probability; Hit with thrombosis; HITT; LMWH; Low molecular weight heparin; OD; Optical density; PF4; Platelet factor 4; Serotonin release assay; SRA; UFH; Unfractionated heparin

Indexed keywords

HEPARIN; FIBRINOLYTIC AGENT;

4TS SCORING SYSTEM; ACCURACY; ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK POPULATION; HUMAN; INTERMEDIATE RISK POPULATION; LABORATORY DIAGNOSIS; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; CHEMICALLY INDUCED; INFANT; MASSACHUSETTS; NEWBORN; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; THROMBOCYTOPENIA; THROMBOSIS; YOUNG ADULT;

ADOLESCENT; BOSTON; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOCYTOPENIA; THROMBOSIS; YOUNG ADULT;

EID: 84961290322     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.09.017     Document Type: Article

References (37)

1. Warkentin TE. Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost 1999;82:439-47.
2. Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 2005;94:132-5.
3. Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007;356:2653-5. discussion 2653-5.
4. Warkentin TE. How I diagnose and manage HIT. Hematology Am Soc Hematol Educ Program 2011;2011:143-9.
5. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparininduced thrombocytopenia. Blood 2000;96:1703-8.
6. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005;106:2710-5.
7. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502-7.
8. Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1999;111:700-6.
9. Spadone D, Clark F, James E, Laster J, Hoch J, Silver D. Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 1992;15:306-11. discussion 11-2.
10. Severin T, Sutor AH. Heparin-induced thrombocytopenia in pediatrics. Semin Thromb Hemost 2001;27:293-9.
11. Avila ML, Shah V, Brandao LR. Systematic review on heparin-induced thrombocytopenia in children: a call to action. J Thromb Haemost 2013;11:660-9.
12. Vakil NH, Kanaan AO, Donovan JL. Heparin-induced thrombocytopenia in the pediatric population: a review of current literature. J Pediatr Pharmacol Ther 2012;17:12-30.
13. Takemoto CM, Streiff MB. Heparin-induced thrombocytopenia screening and management in pediatric patients. Hematology Am Soc Hematol Educ Program 2011;2011:162-9.
14. Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, et al. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost 2007;5:1666-73.
15. Price EA, Hayward CP, Moffat KA, Moore JC, Warkentin TE, Zehnder JL. Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories. Thromb Haemost 2007;98:1357-61.
16. Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. Laboratory testing for the antibodies that cause heparininduced thrombocytopenia: how much class do we need? J Lab Clin Med 2005;146:341-6.
17. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003;2:148-57.
18. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparininduced thrombocytopenia in two clinical settings. J Thromb Haemost 2006;4:759-65.
19. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003;121:535-55.
20. Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 2010;8:2642-50.
21. Bryant A, Low J, Austin S, Joseph JE. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay. Br J Haematol 2008;143:721-6.
22. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol 2007;82:1037-43.
23. Pouplard C, Gueret P, Fouassier M, Ternisien C, Trossaert M, Regina S, et al. Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2007;5:1373-9.
24. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparininduced thrombocytopenia. J Thromb Haemost 2004;2:2133-7.
25. Altuntas F, Matevosyan K, Burner J, Shen YM, Sarode R. Higher optical density of an antigen assay predicts thrombosis in patients with heparininduced thrombocytopenia. Eur J Haematol 2008;80:429-35.
26. Weiss BM, Shumway NM, Howard RS, Ketchum LK, Reid TJ. Optical density values correlate with the clinical probability of heparin induced thrombocytopenia. J Thromb Thrombolysis 2008;26:243-7.
27. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986;67:27-30.
28. Pouplard C, Amiral J, Borg JY, Vissac AM, Delahousse B, Gruel Y. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on crossreactivity with danaparoid sodium. Br J Haematol 1997;99:273-80.
29. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2006;355:809-17.
30. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, et al. Prevalence of heparin-associated antibodieswithout thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242-6.
31. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001;103:1838-43.
32. Lubenow N, Eichler P, Lietz T, Greinacher A. Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost 2005;3:2428-36.
33. Warkentin TE. Optical densities reduce odds of heparin-induced thrombocytopenia over-diagnosis. Am J Med 2012;125:3-4.
34. Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost 2004;91:719-24.
35. Boning A, Morschheuser T, Blase U, Scheewe J, von der Brelie M, Grabitz R, et al. Incidence of heparin-induced thrombocytopenia and therapeutic strategies in pediatric cardiac surgery. Ann Thorac Surg 2005;79:62-5.
36. Ranze O, Ranze P, Magnani HN, Greinacher A. Heparin-induced thrombocytopenia in paediatric patients - a review of the literature and a new case treated with danaparoid sodium. Eur J Pediatr 1999; 158(Suppl 3):S130-3.
37. Gruel Y, Pouplard C, Nguyen P, Borg JY, Derlon A, Juhan-Vague I, et al. Biological and clinical features of low-molecular-weight heparininduced thrombocytopenia. Br J Haematol 2003;121:786-92.